Anna Babinska

Prof. Anna Babinska


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2011 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
BABani M Azari
Bani M Azari
JMJonathan D Marmur
Jonathan D Marmur
MSMoro O Salifu
Moro O Salifu
YEYigal H Ehrlich
Yigal H Ehrlich
EKElizabeth Kornecki
Elizabeth Kornecki
ABAnna Babinska
Anna Babinska
Background -: The F11 Receptor (F11R; aka JAM-A, JAM-1) is a cell adhesion protein present constitutively on the membrane surface of circulating platelets and within tight junctions of endothelial cells (ECs). Previous reports demonstrated that exposure of ECs to pro-inflammatory cytokines causes insertion of F11R molecules into the luminal surface of ECs, ensuing with homologous interactions between F11R molecules of platelets and ECs, and a resultant adhesion of platelets to the inflamed ECs. The main new finding of the present report is that the first step in this chain of events is thede-novotranscription and translation of F11R molecules, induced in ECs by exposure to inflammatory cytokines.Methods -: The experimental approach utilized isolated, washed human platelet suspensions and cultured human venous endothelial cells (HUVEC) and human arterial endothelial cells (HAEC) exposed to the proinflammatory cytokines TNF-alpha and/or IFN-gamma, for examination of the ability of human platelets to adhere to the inflamed ECs thru the F11R. Our strategy was based on testing the effects of the following inhibitors on this activity: general mRNA synthesis inhibitors, inhibitors of the NF-kappaB and JAK/STAT pathways, and small interfering F11R-mRNA (siRNAs) to specifically silence the F11R gene.Results -: Treatment of inflamed ECs with the inhibitors actinomycin, parthenolide or with AG-480 resulted in complete blockade of F11R- mRNA expression, indicating the involvement of NF-kappaB and JAK/STAT pathways in this induction. Transfection of ECs with F11R siRNAs caused complete inhibition of the cytokine-induced upregulation of F11R mRNA and inhibition of detection of the newly- translated F11R molecules in cytokine-inflamed ECs. The functional consequence of the inhibition of F11R transcription and translation was the significant blockade of the adhesion of human platelets to inflamed ECs.Conclusion -: These results prove thatde novosynthesis of F11R in ECs is required for the adhesion of platelets to inflamed ECs. Because platelet adhesion to an inflamed endothelium is crucial for plaque formation in non-denuded blood vessels, we conclude that thede-novotranslation of F11R is a crucial early step in the initiation of atherogenesis, leading to atherosclerosis, heart attacks and stroke.

15 April 2000
Verified
Journal Article
Closed access
MSM B Sobocka
M B Sobocka
TST Sobocki
T Sobocki
PBP Banerjee
P Banerjee
CWC Weiss
C Weiss
JRJ I Rushbrook
J I Rushbrook
EKE Kornecki
E Kornecki

7 May 2014 in Peptide Science
Verified
Journal Article
Closed access
PDF file
ABAnna Babinska
Anna Babinska
Cristina Corina ClementCristina Corina Clement
Cristina Corina Clement
MSM. Swiatkowska
M. Swiatkowska
JSJ. Szymanski
J. Szymanski
ASA. Shon
A. Shon
MSM. O. Salifu
M. O. Salifu

1 November 1996 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
ABAnna Babinska
Anna Babinska
YEY. H. Ehrlich
Y. H. Ehrlich
EKE. Kornecki
E. Kornecki
A monoclonal antibody that inhibits protein kinase C (PKC) activity, as well as PKC pseudosubstrate inhibitory peptides, was found to cause aggregation of human platelets followed by granular secretion. Binding of this antibody to the platelet surface was demonstrated directly by flow cytometry and immunofluorescence microscopy. Assays of ecto-protein kinase activity revealed that this antibody inhibits the phosphorylation of five proteins on the platelet surface. The platelet aggregation induced by extracellular PKC inhibitors could be blocked by the addition of the membrane-impermeable phosphatase inhibitor, microcystin. Thus the inhibition of surface protein phosphorylation together with continuous dephosphorylation, namely, a decrease in the phosphorylation state of surface proteins, causes the activation of platelets. The aggregation caused by decreased surface phosphorylation appears to be initiated by the exposure of active fibrinogen-binding sites on the platelet surface, as demonstrated by the formation of fibrinogen-dependent microaggregates, as the first step in this process. We conclude that the phosphorylation of surface proteins by a platelet ecto-protein kinase C protects platelets from spontaneous aggregation and thus can play an important role in homeostatic mechanisms that maintain circulating platelets in a resting state.

1 January 1998
Verified
Journal Article
Closed access
YEY H Ehrlich
Y H Ehrlich
MHM V Hogan
M V Hogan
ZPZ Pawlowska
Z Pawlowska
AWA Wieraszko
A Wieraszko
EKE Katz
E Katz
EKE Kornecki
E Kornecki